Gastrointestinal Manifestations of HIV Infection

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2000 Sep 12

PMID 10981025

Citations 5

Authors

M R Wallace

O S Brann

Affiliations

Soon will be listed here.

Abstract

Since the beginning of the AIDS pandemic, gastrointestinal (GI) problems have been among the most common features of the disease. Despite the introduction of highly active antiretroviral therapy (HAART) in 1995 and 1996, most HIV-infected patients continue to have GI complications. The clinician must be able to diagnose and treat the opportunistic gastrointestinal infections and neoplasms that occur in the advanced AIDS patient, as well as the treatment-induced symptoms and non-HIV-related GI disorders that predominate in early HIV disease. This review addresses the GI manifestations of HIV, with particular emphasis on new developments in the era of highly effective therapy.

Citing Articles

Prevalence of and risk for gastrointestinal bleeding and peptic ulcerative disorders in a cohort of HIV patients from a U.S. healthcare claims database.

Bratton E, Vannappagari V, Kobayashi M PLoS One. 2017; 12(6):e0180612.

PMID: 28666006 PMC: 5493421. DOI: 10.1371/journal.pone.0180612.

Human immunodeficiency virus (HIV) is highly associated with giant idiopathic esophageal ulcers in acquired immunodeficiency syndrome (AIDS) patients.

Lv B, Cheng X, Gao J, Zhao H, Chen L, Wang L Am J Transl Res. 2016; 8(10):4464-4471.

PMID: 27830031 PMC: 5095340.

HAART toxicity masquerading as a surgical abdomen.

Feghali A, Wang Y, Irizarry E, Lueders M Int J Surg Case Rep. 2015; 18:33-6.

PMID: 26686487 PMC: 4701868. DOI: 10.1016/j.ijscr.2015.11.028.

Prevalence of Helicobacter pylori in HIV-infected, HAART-naïve Ugandan children: a hospital-based survey.

Hestvik E, Tylleskar T, Ndeezi G, Grahnquist L, Olafsdottir E, Tumwine J J Int AIDS Soc. 2011; 14:34.

PMID: 21714943 PMC: 3152504. DOI: 10.1186/1758-2652-14-34.

HIV and the Gastrointestinal Tract.

Crum-Cianflone N Infect Dis Clin Pract (Baltim Md). 2011; 18(5):283-285.

PMID: 21547005 PMC: 3085187. DOI: 10.1097/IPC.0b013e3181f1038b.

References

Mahajani R, Uzer M . Cholangiopathy in HIV-infected patients. Clin Liver Dis. 2001; 3(3):669-84, x. DOI: 10.1016/s1089-3261(05)70090-8. View

Clark D . New insights into human cryptosporidiosis. Clin Microbiol Rev. 1999; 12(4):554-63. PMC: 88924. DOI: 10.1128/CMR.12.4.554. View

Wanke C, Gerrior J, Blais V, Mayer H, Acheson D . Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis. 1998; 178(5):1369-72. DOI: 10.1086/314443. View

Endres J, Salky B . Laparoscopy in AIDS. Gastrointest Endosc Clin N Am. 1998; 8(4):975-90. View

Quinn T . Diversity of Campylobacter species and its impact on patients infected with human immunodeficiency virus. Clin Infect Dis. 1997; 24(6):1114-7. DOI: 10.1086/513645. View

Bini E, Micale P, Weinshel E . Risk factors for rebleeding and mortality from acute upper gastrointestinal hemorrhage in human immunodeficiency virus infection. Am J Gastroenterol. 1999; 94(2):358-63. DOI: 10.1111/j.1572-0241.1999.858_a.x. View

Manocha A, Sossenheimer M, Martin S, Sherman K, Venkatesan T, Whitcomb D . Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). Am J Gastroenterol. 1999; 94(3):784-9. DOI: 10.1111/j.1572-0241.1999.00951.x. View

Danzig J, Brandt L, Reinus J, Klein R . Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol. 1991; 86(6):715-8. View

Grohmann G, Glass R, Pereira H, Monroe S, Hightower A, Weber R . Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. N Engl J Med. 1993; 329(1):14-20. DOI: 10.1056/NEJM199307013290103. View

10.

Bonacini M, Laine L . Esophageal disease in patients with AIDS: diagnosis and treatment. Gastrointest Endosc Clin N Am. 1998; 8(4):811-23. View

11.

Perez-Olmeda M, Gonzalez J, Garcia-Samaniego J, Arribas J, Pena J, Soriano V . Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C. J Acquir Immune Defic Syndr. 2000; 22(3):308-9. DOI: 10.1097/00126334-199911010-00014. View

12.

Barrett W, Callahan T, Orkin B . Perianal manifestations of human immunodeficiency virus infection: experience with 260 patients. Dis Colon Rectum. 1998; 41(5):606-11; discussion 611-2. DOI: 10.1007/BF02235268. View

13.

Hashmey R, Smith N, Cron S, Graviss E, Chappell C, White Jr A . Cryptosporidiosis in Houston, Texas. A report of 95 cases. Medicine (Baltimore). 1997; 76(2):118-39. DOI: 10.1097/00005792-199703000-00004. View

14.

Wilcox C . Esophageal strictures complicating ulcerative esophagitis in patients with AIDS. Am J Gastroenterol. 1999; 94(2):339-43. DOI: 10.1111/j.1572-0241.1999.00853.x. View

15.

Monkemuller K, Call S, Lazenby A, Wilcox C . Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol. 2000; 95(2):457-62. DOI: 10.1111/j.1572-0241.2000.01768.x. View

16.

Goldie S, Kuntz K, Weinstein M, Freedberg K, Welton M, Palefsky J . The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999; 281(19):1822-9. DOI: 10.1001/jama.281.19.1822. View

17.

Smith N, Cron S, Valdez L, Chappell C, White Jr A . Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998; 178(3):900-3. DOI: 10.1086/515352. View

18.

Cappell M, GELLER A . The high mortality of gastrointestinal bleeding in HIV-seropositive patients: a multivariate analysis of risk factors and warning signs of mortality in 50 consecutive patients. Am J Gastroenterol. 1992; 87(7):815-24. View

19.

Lambl B, Federman M, Pleskow D, Wanke C . Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS. 1996; 10(7):739-44. DOI: 10.1097/00002030-199606001-00007. View

20.

Jacobson J, Spritzler J, Fox L, Fahey J, Jackson J, Chernoff M . Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999; 180(1):61-7. DOI: 10.1086/314834. View